FDA Drug recall D-0367-2021
Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01
- FDA Drug
- Class III
- terminated
- Published 2021-05-12
On 2021-05-12 the FDA classified a Class III recall of Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01 by Heritage Pharmaceuticals, citing labeling: Incorrect or Missing Lot and/or Exp Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0367-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2021-04-21 |
| Published | 2021-05-12 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Heritage Pharmaceuticals |
| Distribution | OH |
Product
Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Identifiers
| ndc | 23155-227-01 |
|---|---|
| ndc | 23155-227-05 |
| ndc | 23155-228-01 |
| ndc | 23155-228-05 |
| code_info | Lot A120036, Exp DEC 2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0367-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.